Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection-Reference-Cited by-同舟云学术

Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection

Published:2017-03-13 Issue:8 Volume:64 Page:1017-1025
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Herrick Jesica A.¹,Legrand Fanny¹,Gounoue Raceline²,Nchinda Godwin³,Montavon Céline⁴,Bopda Jean⁵,Tchana Steve Mbickmen⁵,Ondigui Bienvenu Etogo⁶,Nguluwe Konrad⁷,Fay Michael P.⁸,Makiya Michelle¹,Metenou Simon¹,Nutman Thomas B.¹,Kamgno Joseph⁵⁹,Klion Amy D.¹

Affiliation:

1. Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

2. Faculty of Sciences, University of Yaoundé I, and

3. Laboratory of Immunology, Chantal Biya International Reference Centre for Research on Prevention and Management of HIV/AIDS, Yaoundé, Cameroon

4. Institut de recherche pour le développement, Montpellier, France

5. Center for Research on Filariasis and Other Tropical Diseases, Yaoundé,

6. Central Hospital of Yaoundé,

7. District Hospital of Akonolinga, Cameroon

8. Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

9. Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/64/8/1017/24254702/cix016.pdf

Reference25 articles.

1. Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation;Klion;J Infect Dis,1991

2. Eosinophil-associated processes underlie differences in clinical presentation of loiasis between temporary residents and those indigenous to Loa-endemic areas;Herrick;Clin Infect Dis,2015

3. Five cases of encephalitis during treatment of loiasis with diethylcarbamazine;Carme;Am J Trop Med Hyg,1991

4. Report of a scientific working group on serious adverse events following Mectizan treatment of onchocerciasis in Loa loa endemic areas;Scientific Working Group on Serious Adverse Events in Loa Loa Endemic Areas;Filaria J,2004

5. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection;Gardon;Lancet,1997

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis;The Lancet Infectious Diseases;2023-10

2. Evaluating post-treatment Loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis;LANCET MICROBE;2023

3. Evaluating post-treatment Loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis;The Lancet Microbe;2023-02

4. Clinical Aspects: Treatment of Simple and Complicated Forms of Loiasis;Loa loa: Latest Advances in Loiasis Research;2023

5. Eosinophils in filarial infections: Inducers of protection or pathology?;Frontiers in Immunology;2022-10-31